Showing results (1421-1430 of 1,479) with videos related to
Sort By:
Pageof 148
Nature Medicine|November 8, 2016
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastasesSophia Frentzas, Eve Simoneau, Victoria L Bridgeman, et al.Circulation|September 1, 2020
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA TrialRenato D Lopes, Karen P Alexander, Susanna R Stevens, et al.AIDS Care|March 17, 2007
Symptom management and self-care for peripheral neuropathy in HIV/AIDSP K Nicholas, J K Kemppainen, G E Canaval, et al.Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.MMWR. Morbidity and Mortality Weekly Report|March 24, 2017
Establishing a Timeline to Discontinue Routine Testing of Asymptomatic Pregnant Women for Zika Virus Infection - American Samoa, 2016-2017W Thane Hancock, Heidi M Soeters, Susan L Hills, et al.Circulation|June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled TrialScott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.AIDS Care|December 12, 2007
Unhealthy behaviours for self-management of HIV-related peripheral neuropathyP K Nicholas, J G Voss, I B Corless, et al.European Heart Journal|August 5, 2024
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trialNick S Nurmohamed, James K Min, Rebecca Anthopolos, et al.Chest|November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.European Heart Journal|September 13, 2021
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trialJose L Lopez-Sendon, Derek D Cyr, Daniel B Mark, et al.Pageof 148